Harvard Bioscience (HBIO) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Harvard Bioscience (HBIO) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.50% |
| Dec 31, 2025 | -128.92% |
| Sep 30, 2025 | 46.10% |
| Jun 30, 2025 | 95.46% |
| Mar 31, 2025 | -14,070.56% |
| Dec 31, 2024 | 107.51% |
| Sep 30, 2024 | -63.68% |
| Jun 30, 2024 | 37.64% |
| Mar 31, 2024 | -907.30% |
| Dec 31, 2023 | 62.39% |
| Sep 30, 2023 | -26.43% |
| Jun 30, 2023 | -261.45% |
| Mar 31, 2023 | 136.43% |
| Dec 31, 2022 | 51.07% |
| Sep 30, 2022 | -239.84% |
| Jun 30, 2022 | 135.20% |
| Mar 31, 2022 | -707.91% |
| Dec 31, 2021 | 769.41% |
| Sep 30, 2021 | 60.65% |
| Jun 30, 2021 | 35.43% |